ZSTK vs. NVO
ZSTK (ZeroStack Corp.) and NVO (Novo Nordisk A/S) are both stocks. ZSTK operates in Asset Management (Financial Services), while NVO operates in Drug Manufacturers - General (Healthcare). Over the past 5 years, ZSTK returned -72.88%/yr vs 4.55%/yr for NVO. At a 0.09 correlation, their price movements are largely independent.
Performance
ZSTK vs. NVO - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ZSTK achieves a -35.46% return, which is significantly lower than NVO's -6.67% return.
ZSTK
- 1D
- 0.00%
- 1M
- -5.50%
- YTD
- -35.46%
- 6M
- -46.53%
- 1Y
- -84.28%
- 3Y*
- -67.86%
- 5Y*
- -72.88%
- 10Y*
- —
NVO
- 1D
- 6.23%
- 1M
- 2.05%
- YTD
- -6.67%
- 6M
- -1.28%
- 1Y
- -34.91%
- 3Y*
- -14.58%
- 5Y*
- 4.55%
- 10Y*
- 8.27%
ZSTK vs. NVO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
ZSTK ZeroStack Corp. | -35.46% | -84.42% | -23.70% | -70.34% | -87.21% | -67.64% |
NVO Novo Nordisk A/S | -6.67% | -39.22% | -15.93% | 54.84% | 22.66% | 47.63% |
Correlation
The correlation between ZSTK and NVO is 0.19, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.19 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.09 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.10 |
Correlation (All Time) Calculated using the full available price history since May 11, 2021 | 0.09 |
Fundamentals
ZSTK:
-$221.74
NVO:
DKK 27.42
ZSTK:
0.09
NVO:
4.06
ZSTK:
$23.89M
NVO:
DKK 327.80B
ZSTK:
-$7.71M
NVO:
DKK 268.30B
ZSTK:
-$9.88M
NVO:
DKK 181.54B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ZSTK vs. NVO — Risk / Return Rank
ZSTK
NVO
ZSTK vs. NVO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ZeroStack Corp. (ZSTK) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ZSTK | NVO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.09 | ||
| Sortino ratioReturn per unit of downside risk | -0.20 | ||
| Omega ratioGain probability vs. loss probability | 0.89 | 0.90 | -0.01 |
| Calmar ratioReturn relative to maximum drawdown | -0.96 | -0.71 | -0.25 |
| Martin ratioReturn relative to average drawdown | -1.29 | -1.13 | -0.15 |
Loading charts...
Drawdowns
ZSTK vs. NVO - Drawdown Comparison
The maximum ZSTK drawdown since its inception was -99.97%, which is greater than NVO's maximum drawdown of -74.70%. Use the drawdown chart below to compare losses from any high point for ZSTK and NVO.
Loading charts...
Drawdown Indicators
| ZSTK | NVO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.97% | -74.70% | -25.27% |
Max Drawdown (1Y)Largest decline over 1 year | -87.94% | -49.17% | -38.77% |
Max Drawdown (3Y)Largest decline over 3 years | -97.30% | -74.70% | -22.60% |
Max Drawdown (5Y)Largest decline over 5 years | -99.97% | -74.70% | -25.27% |
Max Drawdown (10Y)Largest decline over 10 years | — | -74.70% | — |
Current DrawdownCurrent decline from peak | -99.97% | -66.66% | -33.31% |
Average DrawdownAverage peak-to-trough decline | -92.49% | -17.81% | -74.68% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 65.47% | 32.54% | +32.93% |
Volatility
ZSTK vs. NVO - Volatility Comparison
ZeroStack Corp. (ZSTK) has a higher volatility of 21.59% compared to Novo Nordisk A/S (NVO) at 11.74%. This indicates that ZSTK's price experiences larger fluctuations and is considered to be riskier than NVO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ZSTK | NVO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 21.59% | 11.74% | +9.85% |
Volatility (6M)Calculated over the trailing 6-month period | 107.61% | 38.27% | +69.34% |
Volatility (1Y)Calculated over the trailing 1-year period | 144.85% | 52.05% | +92.80% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 137.70% | 38.45% | +99.25% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 137.17% | 32.60% | +104.57% |
Dividends
ZSTK vs. NVO - Dividend Comparison
ZSTK has not paid dividends to shareholders, while NVO's dividend yield for the trailing twelve months is around 3.93%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
NVO Novo Nordisk A/S | 3.93% | 3.31% | 1.68% | 1.00% | 1.20% | 1.35% | 1.87% | 2.14% | 1.45% | 1.52% | 2.87% | 0.92% |
ZSTK ZeroStack Corp. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
ZSTK vs. NVO - Financials Comparison
This section allows you to compare key financial metrics between ZeroStack Corp. and Novo Nordisk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
ZSTK and NVO have a correlation of 0.19, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ZSTK has higher volatility (21.59%) compared to NVO (11.74%). In terms of maximum drawdown, ZSTK dropped -99.97% vs NVO's -74.70%.
ZSTK currently has the higher Sharpe Ratio (-0.58 vs -0.67), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ZSTK and NVO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer